KPIs & Operating Metrics(New)
Growth Metrics

Johnson & Johnson (JNJ) Net Cash Flow (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 29, 2026 37.73%
Dec 28, 2025 585.00%
Sep 28, 2025 98.50%
Jun 29, 2025 -240.23%
Mar 30, 2025 230.77%
Dec 29, 2024 186.17%
Sep 29, 2024 -883.73%
Jun 30, 2024 -113.64%
Mar 31, 2024 86.39%
Dec 31, 2023 255.87%
Oct 1, 2023 76.96%
Jul 2, 2023 -143.94%
Apr 2, 2023 435.18%
Oct 3, 2021 108.17%
Jul 4, 2021 230.74%
Apr 4, 2021 76.25%
Jan 3, 2021 -167.06%
Sep 27, 2020 275.29%
Jun 28, 2020 -187.84%
Mar 29, 2020 -256.62%
Dec 29, 2019 -50.63%
Sep 29, 2019 631.82%
Jun 30, 2019 88.97%
Mar 31, 2019 -262.75%
Dec 30, 2018 241.32%
Sep 30, 2018 -146.00%
Jul 1, 2018 197.42%
Apr 1, 2018 -259.43%
Dec 31, 2017 -31.62%
Oct 1, 2017 135.95%
Jul 2, 2017 -559.33%
Apr 2, 2017 -64.57%
Sep 27, 2015 484.95%
Jun 28, 2015 60.03%
Mar 29, 2015 -360.19%
Dec 28, 2014 351.99%
Sep 28, 2014 93.98%
Jun 29, 2014 -368.19%
Mar 30, 2014 -130.99%
Dec 29, 2013 3,094.40%
Sep 29, 2013 -104.99%
Jun 30, 2013 2,482.47%
Mar 31, 2013 116.22%
Dec 30, 2012 -143.02%
Sep 30, 2012 108.61%
Jul 1, 2012 -384.69%
Apr 1, 2012 -15.52%
Oct 3, 2010 258.52%
Jul 4, 2010 54.27%
Apr 4, 2010 -150.34%
Jan 3, 2010 133,466.67%
Sep 27, 2009 99.70%
Jun 28, 2009 -153.11%